Multigene measurable residual disease assessment improves AML relapse risk stratification in autologous hematopoietic cell transplantation

We report here the largest study to date of adult AML patients tested for measurable residual disease (MRD) at the time of autologous hematopoietic cell transplantation (auto-HCT). Seventy-two adult patients transplanted between 2004–2013 at a single academic medical center (UCSF) were eligible for...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Biol Blood Marrow Transplant
Main Authors: Mulé, Matthew P., Mannis, Gabriel N., Wood, Brent L., Radich, Jerald P., Hwang, Jimmy, Ramos, Nestor R., Andreadis, Charalambos, Damon, Lloyd, Logan, Aaron C., Martin, Thomas G., Hourigan, Christopher S.
Formato: Artigo
Idioma:Inglês
Publicado: 2016
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5072749/
https://ncbi.nlm.nih.gov/pubmed/27544285
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2016.08.014
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares